| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
19,043 |
16,788 |
$4.43M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
7,854 |
6,417 |
$4.27M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
19,297 |
7,350 |
$3.62M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,992 |
10,902 |
$2.97M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,511 |
11,240 |
$2.55M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
11,773 |
9,363 |
$2.29M |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,930 |
4,472 |
$1.28M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,728 |
1,561 |
$1.16M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
17,422 |
13,695 |
$1.14M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,498 |
4,132 |
$1.02M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,029 |
4,581 |
$1.01M |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
12,463 |
4,645 |
$976K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,230 |
1,120 |
$942K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,199 |
1,992 |
$864K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
7,522 |
4,285 |
$861K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
7,470 |
3,194 |
$847K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,304 |
2,873 |
$769K |
| 96415 |
|
1,757 |
1,150 |
$601K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,933 |
2,549 |
$565K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
4,743 |
2,033 |
$553K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,420 |
2,261 |
$541K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,408 |
1,300 |
$539K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,169 |
2,793 |
$534K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,908 |
2,513 |
$514K |
| 29581 |
|
3,526 |
1,170 |
$489K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,186 |
824 |
$463K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,597 |
2,364 |
$442K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
897 |
685 |
$434K |
| 74183 |
|
1,215 |
1,108 |
$423K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,257 |
1,172 |
$413K |
| G0378 |
Hospital observation service, per hour |
5,703 |
3,306 |
$371K |
| 97161 |
|
1,496 |
1,367 |
$337K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,417 |
1,287 |
$330K |
| 97162 |
|
1,509 |
1,389 |
$326K |
| 96367 |
|
2,129 |
1,306 |
$317K |
| 76642 |
|
1,785 |
1,647 |
$302K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
289 |
275 |
$279K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
626 |
508 |
$276K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,206 |
1,103 |
$275K |
| 76830 |
Ultrasound, transvaginal |
2,242 |
2,091 |
$241K |
| 97597 |
|
1,448 |
1,025 |
$204K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
140 |
132 |
$204K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
995 |
895 |
$199K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,830 |
1,664 |
$196K |
| 80053 |
Comprehensive metabolic panel |
27,185 |
19,549 |
$169K |
| 73562 |
|
3,609 |
3,196 |
$147K |
| 11043 |
|
334 |
251 |
$144K |
| 93971 |
|
1,278 |
1,170 |
$137K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
738 |
716 |
$125K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,685 |
1,619 |
$124K |
| 71046 |
Radiologic examination, chest; 2 views |
6,688 |
6,034 |
$122K |
| 59025 |
Fetal non-stress test |
382 |
307 |
$120K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,235 |
1,104 |
$120K |
| 71250 |
|
1,495 |
1,334 |
$118K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
91 |
86 |
$114K |
| 97165 |
|
835 |
768 |
$114K |
| 73564 |
|
939 |
867 |
$89K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
570 |
529 |
$81K |
| 73502 |
|
2,004 |
1,798 |
$79K |
| 72100 |
|
1,882 |
1,684 |
$78K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,769 |
1,615 |
$77K |
| J0485 |
Injection, belatacept, 1 mg |
128 |
49 |
$75K |
| 93970 |
|
428 |
384 |
$73K |
| 72141 |
|
368 |
325 |
$71K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
26,358 |
19,306 |
$71K |
| 73030 |
|
2,206 |
1,958 |
$70K |
| 86832 |
|
1,083 |
916 |
$64K |
| 72040 |
|
1,416 |
1,264 |
$63K |
| 93976 |
|
627 |
565 |
$59K |
| J1453 |
Injection, fosaprepitant, 1 mg |
434 |
222 |
$58K |
| 87497 |
|
3,937 |
2,151 |
$52K |
| 93975 |
|
253 |
235 |
$51K |
| 77062 |
|
770 |
731 |
$51K |
| 73630 |
|
3,112 |
2,683 |
$50K |
| 97163 |
|
280 |
257 |
$49K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,803 |
4,045 |
$48K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
5,886 |
5,260 |
$48K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,291 |
12,304 |
$47K |
| 70496 |
|
120 |
108 |
$46K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
52,745 |
36,590 |
$46K |
| 86833 |
|
1,085 |
916 |
$40K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
222 |
211 |
$39K |
| 97116 |
|
516 |
213 |
$38K |
| 76536 |
|
253 |
226 |
$38K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
259 |
202 |
$37K |
| 72197 |
|
56 |
50 |
$34K |
| 80197 |
|
5,617 |
2,923 |
$33K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
625 |
522 |
$31K |
| 76775 |
|
256 |
238 |
$31K |
| 77066 |
Tomosynthesis, mammo |
1,436 |
1,349 |
$30K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
20 |
14 |
$30K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,567 |
5,005 |
$30K |
| 73610 |
|
2,525 |
2,129 |
$27K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
38 |
25 |
$24K |
| 87799 |
|
3,234 |
1,814 |
$23K |
| 71045 |
Radiologic examination, chest; single view |
5,298 |
4,721 |
$22K |
| 86834 |
|
365 |
292 |
$22K |
| 99215 |
Prolong outpt/office vis |
126 |
108 |
$22K |
| 73130 |
|
1,267 |
1,139 |
$21K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
614 |
566 |
$21K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,702 |
1,635 |
$21K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
10,236 |
9,014 |
$20K |
| 43235 |
|
44 |
39 |
$20K |
| 70486 |
|
271 |
257 |
$19K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
166 |
109 |
$18K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
87 |
77 |
$18K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,653 |
7,899 |
$18K |
| 73110 |
|
1,017 |
887 |
$16K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
32 |
29 |
$15K |
| 20550 |
|
61 |
50 |
$14K |
| 80076 |
|
7,305 |
6,021 |
$14K |
| 70491 |
|
93 |
87 |
$14K |
| 96402 |
|
350 |
301 |
$13K |
| 83735 |
|
13,921 |
7,979 |
$12K |
| C1769 |
Guide wire |
1,946 |
1,641 |
$12K |
| 93017 |
|
129 |
115 |
$11K |
| 82248 |
|
2,916 |
1,808 |
$11K |
| 88341 |
|
376 |
316 |
$11K |
| 80047 |
|
1,649 |
1,495 |
$11K |
| 83880 |
|
2,345 |
2,138 |
$10K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
172 |
154 |
$10K |
| 86850 |
|
4,589 |
3,365 |
$9K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
31 |
28 |
$9K |
| 73560 |
|
131 |
122 |
$9K |
| 85610 |
|
9,701 |
7,204 |
$9K |
| 86923 |
|
131 |
85 |
$8K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
43 |
38 |
$8K |
| 86900 |
|
5,150 |
3,743 |
$8K |
| 95886 |
|
47 |
40 |
$8K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
249 |
229 |
$8K |
| 96376 |
|
4,048 |
2,521 |
$8K |
| 95811 |
|
27 |
24 |
$8K |
| 84484 |
|
8,245 |
7,031 |
$7K |
| 86835 |
|
366 |
292 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
20,585 |
15,785 |
$7K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
36 |
28 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,261 |
1,135 |
$6K |
| 84100 |
|
9,939 |
5,469 |
$5K |
| 82728 |
|
1,884 |
1,623 |
$5K |
| 77065 |
Tomosynthesis, mammo |
111 |
105 |
$5K |
| 81001 |
|
14,983 |
12,401 |
$5K |
| 97035 |
|
44 |
12 |
$5K |
| 90715 |
|
186 |
177 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
557 |
507 |
$4K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
162 |
124 |
$4K |
| 87581 |
|
871 |
783 |
$4K |
| 82962 |
|
12,121 |
8,520 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,825 |
4,376 |
$4K |
| 88307 |
|
172 |
122 |
$4K |
| 85379 |
|
1,142 |
1,061 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
10,856 |
9,272 |
$4K |
| 86828 |
|
364 |
293 |
$4K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
1,521 |
1,397 |
$3K |
| 96523 |
|
88 |
62 |
$3K |
| 73590 |
|
306 |
272 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,553 |
3,989 |
$3K |
| 86901 |
|
5,149 |
3,745 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
412 |
376 |
$3K |
| 87040 |
|
519 |
426 |
$3K |
| 97166 |
|
17 |
14 |
$3K |
| 73620 |
|
226 |
195 |
$3K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
959 |
854 |
$3K |
| 95913 |
|
28 |
24 |
$3K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
8,715 |
7,867 |
$3K |
| 83605 |
|
2,865 |
2,475 |
$3K |
| 88342 |
|
938 |
765 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,300 |
2,503 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
528 |
480 |
$3K |
| 72110 |
|
63 |
52 |
$3K |
| 83690 |
|
7,275 |
6,311 |
$3K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$2K |
| 82570 |
|
4,145 |
2,867 |
$2K |
| 97535 |
Self-care/home management training, each 15 minutes |
27 |
12 |
$2K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
188 |
146 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
528 |
479 |
$2K |
| 87486 |
|
624 |
579 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14,129 |
10,602 |
$2K |
| 83615 |
|
2,754 |
2,017 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,340 |
3,070 |
$2K |
| 84702 |
|
1,904 |
1,582 |
$2K |
| 73140 |
|
152 |
126 |
$2K |
| 87070 |
|
1,862 |
1,586 |
$2K |
| 83970 |
|
472 |
416 |
$2K |
| 85027 |
|
1,120 |
896 |
$2K |
| C9399 |
Unclassified drugs or biologicals |
1,780 |
1,548 |
$2K |
| C1776 |
Joint device (implantable) |
13 |
13 |
$2K |
| 82977 |
|
365 |
192 |
$2K |
| 83550 |
|
1,264 |
1,121 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,944 |
2,527 |
$1K |
| 77073 |
|
45 |
40 |
$1K |
| 70498 |
|
31 |
26 |
$1K |
| 77061 |
|
15 |
15 |
$1K |
| 83540 |
|
1,357 |
1,205 |
$1K |
| 83520 |
|
205 |
165 |
$1K |
| 76937 |
|
36 |
27 |
$1K |
| 88304 |
|
196 |
167 |
$1K |
| 74018 |
|
79 |
67 |
$1K |
| 76801 |
|
182 |
145 |
$1K |
| J7050 |
Infusion, normal saline solution, 250 cc |
8,431 |
4,922 |
$1K |
| 82607 |
|
1,300 |
1,145 |
$1K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
682 |
561 |
$1K |
| 84156 |
|
3,396 |
2,193 |
$1K |
| 88185 |
|
48 |
36 |
$1K |
| 85730 |
|
2,449 |
1,893 |
$1K |
| 84439 |
|
1,199 |
1,052 |
$906.30 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,710 |
1,306 |
$891.54 |
| 90686 |
|
101 |
97 |
$857.95 |
| 87077 |
|
1,570 |
1,336 |
$835.96 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
8,240 |
6,969 |
$811.77 |
| 87340 |
|
541 |
467 |
$788.65 |
| 82803 |
|
2,422 |
2,151 |
$781.02 |
| 82784 |
|
521 |
427 |
$779.84 |
| 73080 |
|
29 |
27 |
$777.38 |
| 80061 |
Lipid panel |
1,044 |
965 |
$752.20 |
| 86140 |
|
1,873 |
1,650 |
$751.81 |
| C1758 |
Catheter, ureteral |
61 |
39 |
$750.06 |
| 80320 |
|
639 |
580 |
$721.67 |
| 81025 |
|
3,584 |
2,990 |
$709.59 |
| 87522 |
Neg quan hep c or qual rna |
145 |
123 |
$698.40 |
| 86592 |
|
602 |
546 |
$688.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
583 |
515 |
$593.84 |
| 84550 |
|
2,356 |
1,503 |
$574.68 |
| 85045 |
|
765 |
612 |
$526.53 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,499 |
4,862 |
$524.34 |
| 96417 |
|
1,202 |
651 |
$476.95 |
| Q3014 |
Telehealth originating site facility fee |
66 |
60 |
$458.96 |
| 88360 |
|
14 |
14 |
$444.82 |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
214 |
120 |
$444.67 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,898 |
1,313 |
$406.51 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
420 |
375 |
$392.03 |
| 82105 |
|
93 |
78 |
$383.62 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
887 |
832 |
$364.83 |
| 88184 |
|
32 |
24 |
$340.42 |
| 85014 |
|
2,717 |
2,472 |
$338.89 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,011 |
2,045 |
$326.21 |
| 77300 |
|
21 |
14 |
$326.09 |
| 76000 |
|
41 |
36 |
$317.00 |
| 84703 |
|
1,511 |
1,399 |
$293.95 |
| 82150 |
|
191 |
117 |
$269.78 |
| 82378 |
|
314 |
228 |
$255.26 |
| 87075 |
|
382 |
319 |
$237.90 |
| 83883 |
|
65 |
55 |
$234.41 |
| 87186 |
|
1,491 |
1,269 |
$233.51 |
| 82550 |
|
737 |
601 |
$232.74 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,707 |
3,893 |
$230.74 |
| 82746 |
|
579 |
516 |
$228.35 |
| 86334 |
|
79 |
68 |
$186.12 |
| 87205 |
|
879 |
725 |
$184.33 |
| 73552 |
|
12 |
12 |
$177.40 |
| 87428 |
|
209 |
199 |
$159.00 |
| 88142 |
|
19 |
14 |
$151.02 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
361 |
334 |
$147.72 |
| 84165 |
|
303 |
263 |
$145.71 |
| 85652 |
|
785 |
710 |
$141.71 |
| 81003 |
|
1,192 |
1,109 |
$135.60 |
| 82330 |
|
512 |
419 |
$125.51 |
| 82077 |
|
1,050 |
943 |
$108.90 |
| 82043 |
|
611 |
570 |
$95.69 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
9,076 |
6,502 |
$92.85 |
| 85651 |
|
640 |
575 |
$89.83 |
| 86481 |
|
14 |
14 |
$87.90 |
| J3490 |
Unclassified drugs |
4,868 |
2,656 |
$86.80 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
84 |
74 |
$83.66 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
286 |
277 |
$70.77 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
84 |
79 |
$55.70 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,905 |
1,982 |
$53.57 |
| 81002 |
|
486 |
446 |
$52.46 |
| 86704 |
|
37 |
29 |
$49.16 |
| J3489 |
Injection, zoledronic acid, 1 mg |
12 |
12 |
$44.62 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,977 |
2,237 |
$43.46 |
| G0008 |
Administration of influenza virus vaccine |
104 |
103 |
$42.40 |
| 86317 |
|
36 |
26 |
$39.98 |
| 82565 |
|
213 |
193 |
$39.77 |
| 99220 |
|
14 |
13 |
$33.18 |
| 84153 |
|
42 |
39 |
$31.27 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,712 |
1,562 |
$31.02 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,278 |
2,068 |
$28.89 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
633 |
425 |
$25.47 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
611 |
256 |
$24.95 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,763 |
1,517 |
$24.55 |
| 82947 |
|
386 |
326 |
$20.58 |
| 82375 |
|
449 |
391 |
$16.70 |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,011 |
1,510 |
$15.46 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
233 |
211 |
$11.19 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
690 |
583 |
$9.68 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
502 |
450 |
$8.74 |
| J2060 |
Injection, lorazepam, 2 mg |
423 |
337 |
$7.76 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
348 |
277 |
$5.98 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,165 |
985 |
$5.81 |
| J1790 |
Injection, droperidol, up to 5 mg |
1,072 |
985 |
$4.87 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
641 |
552 |
$4.56 |
| 84295 |
|
353 |
313 |
$3.50 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
99 |
84 |
$2.01 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
95 |
79 |
$0.90 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
399 |
332 |
$0.87 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
63 |
52 |
$0.52 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
15 |
12 |
$0.26 |
| J1940 |
Injection, furosemide, up to 20 mg |
16 |
12 |
$0.26 |
| 84403 |
|
24 |
24 |
$0.00 |
| C1729 |
Catheter, drainage |
380 |
262 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
21 |
13 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
434 |
318 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
155 |
134 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
236 |
205 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
244 |
212 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
25 |
24 |
$0.00 |
| 0272 |
|
178 |
164 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
30 |
26 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
63 |
53 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
39 |
38 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
26 |
17 |
$0.00 |
| 88313 |
|
15 |
13 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
215 |
180 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
80 |
51 |
$0.00 |
| 0370 |
|
121 |
115 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
32 |
24 |
$0.00 |
| 0710 |
|
134 |
126 |
$0.00 |
| 0250 |
|
594 |
267 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
41 |
37 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
43 |
42 |
$0.00 |
| 94760 |
|
17 |
12 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
16 |
12 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
32 |
25 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
13 |
12 |
$0.00 |
| 84132 |
|
29 |
28 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
30 |
27 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
48 |
39 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
79 |
76 |
$0.00 |